Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion Decides to Retire 3,011,910 Shares of Treasury Stock Worth Approx. KRW 491.8B (068270)

Posted on December 4, 2024July 16, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion Decides to Retire 3,011,910 Shares of Treasury Stock Worth Approx. KRW 491.8B (068270)

Source Facts: Financial Supervisory Service Electronic Disclosure System (DART) / 2024-12-04

Disclosure Type: Decision on Stock Retirement

💡 3-Second Summary

For the purpose of stock price stabilization and enhancing shareholder value, Celltrion has decided to retire 3,011,910 shares of its treasury common stock. The total scheduled retirement amount is KRW 491,829,843,450 based on the book value, with the execution date scheduled for January 6, 2025.

📊 1. [Key Disclosure Content & Major Financial Figures Summary]

  • Type and Number of Shares to be Retired: 3,011,910 common shares (No other classes of shares)
  • Total Number of Issued Shares: 217,078,554 common shares
  • Par Value per Share: KRW 1,000
  • Scheduled Retirement Amount: KRW 491,829,843,450 (Approx. KRW 491.8B)
    • Calculation Base: Book value calculated based on the average acquisition cost of KRW 163,295 per share for treasury shares acquired within the scope of dividendable profit as of the board decision date.
  • Method of Acquisition for Retirement: Previously acquired treasury shares (This filing substitutes the disclosure of treasury stock disposal).
  • Key Schedule & Decision Dates:
    • Scheduled Retirement Date: January 6, 2025 (Subject to change during consultations with relevant authorities)
    • Date of Board Decision: December 4, 2024 (7 outside directors attended, 1 absent)
  • Capital Stock Impact: Pursuant to the proviso of Article 343, Paragraph 1 of the Commercial Act, the retirement of treasury shares acquired within the scope of dividendable profit by board resolution will only decrease the total number of issued shares, with no reduction in the capital stock.

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This filing details Celltrion’s corporate resolution to legally invalidate 3,011,910 shares of common treasury stock previously held by the company. The officially stated objectives of this stock retirement are “stock price stabilization and enhancing shareholder value.”

From a financial perspective, the scale of this retirement is valued at approximately KRW 491.8B based on the book value. Because this retirement is executed within the scope of dividendable profit pursuant to Article 343, Paragraph 1 of the Commercial Act, the corporate capital stock remains unchanged. Instead, the transaction specifically reduces the total number of issued shares (217,078,554 shares) by the amount of retired shares, resulting in a reduction of outstanding shares under the same capital stock structure. While the scheduled retirement date is set for January 6, 2025, the final execution timeline remains subject to potential adjustments pending administrative consultations with relevant authorities.

📝 Editor’s Comment (by K-STOCK Editor)

This share retirement proposal has been authorized by the board of directors, with seven outside directors present and one absent. The core fact is that the transaction involves retiring treasury shares that the company already holds, rather than initiating new market purchases, and this filing legally substitutes any separate treasury stock disposal disclosure.

Investors should note that the scheduled retirement amount of approximately KRW 491.8B is a “book value” computed using the average historical acquisition price of KRW 163,295. Until the physical retirement is finalized, the administrative timeline may be subject to change depending on consultations with regulatory bodies.

Consequently, the objective checkpoints for investors to monitor going forward are twofold: first, whether the physical share retirement is finalized without administrative delays by the scheduled date of January 6, 2025; and second, the subsequent verification of the reduced total issued shares from 217,078,554 shares, which will be confirmed via future registration filings and updated share listings. Tracking these sequential administrative steps represents the necessary pathway to verifying the execution of the retirement.

📢 Disclaimer & Source Information

Source: This content has been structured and newly drafted based on official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest solely with the investor.

Inquiries: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Isu Petasys (007660) Issues 1st Response to ‘Jeio Takeover Scrapping’ Rumors; Stays “Unconfirmed” with 1-Month Window
Next Post: [Disclosure] Hanwha Ocean (042660) Formally Approves KRW 115.2B Debt Guarantee for Philly Shipyard Inc.

Related Posts

[Disclosure] Hanwha Ocean 042660, Final Payment Date for KRW 363.3B Subsidiary Rights Offering Changed to ‘Undetermined’ and Authorized Shares Expanded Disclosures
[Disclosure] Hanwha Aerospace (012450) Amends Acquisition Volume, Amount, and Expected Date Following Completion of KAI Share Purchase Disclosures
[Disclosure] Samsung Electro-Mechanics (009150) Sets Record Date for Annual Shareholder Meeting to Confirm Voting Rights Semiconductors
[Disclosure] Hanwha Ocean (042660) Pre-Announces Q4 2024 Earnings Release Date Scheduled for January 24, 2025 Disclosures
[Disclosure] Samsung Biologics (207940) Stock Futures and Options Post Temporary Suspension, Trading Resumed at 09:30 Disclosures
[Disclosure] Jusung Engineering (036930) to Host Domestic NDR in Yeouido on June 7: 1Q Earnings Review and 1:1 Face-to-Face Meetings with Institutional Investors Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme